MedTrace Logo

Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling

NCT02037035 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-09-08

No results posted yet for this study

Summary

This study is looking at the mechanisms underlying the behavioral effects of ketamine in healthy and depressed individuals.

Conditions

Interventions

DRUG

Ketamine

Sponsors & Collaborators

Principal Investigators

  • Lynnette Averill, PhD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02037035 on ClinicalTrials.gov